Cargando…
Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges
BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has caused a deadly pandemic in the 21st century, resulting in many deaths, economic loss, and international immobility. Vaccination represents the only mechanism to defeat this virus. Several intramuscular vaccines have be...
Autores principales: | Kar, Sanchita, Devnath, Popy, Emran, Talha B., Tallei, Trina E., Mitra, Saikat, Dhama, Kuldeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959423/ https://www.ncbi.nlm.nih.gov/pubmed/35349752 http://dx.doi.org/10.1002/iid3.604 |
Ejemplares similares
-
COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
por: Dhama, Kuldeep, et al.
Publicado: (2022) -
Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum
por: Devnath, Popy, et al.
Publicado: (2021) -
Massive third wave of COVID-19 outbreak in Bangladesh: a co-epidemic of dengue might worsen the situation
por: Devnath, Popy, et al.
Publicado: (2022) -
Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic
por: Tareq, Abu Montakim, et al.
Publicado: (2021) -
Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?
por: Mitra, Saikat, et al.
Publicado: (2022)